Lele Zhang

68 Changle Rd
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Dynamic phenotyping of radioiodine-refractory differentiated thyroid cancer: thyroglobulin trajectories, dual-modal imaging, and genotype-defined treatment resistance.

Dynamic phenotyping of radioiodine-refractory differentiated thyroid cancer: thyroglobulin trajectories, dual-modal imaging, and genotype-defined treatment resistance.

Journal: Frontiers in endocrinology

Published: May 26, 2026

Clinical and Procedural Predictive Model for Pneumothorax Risk After CT-Guided Lung Biopsy.

Clinical and Procedural Predictive Model for Pneumothorax Risk After CT-Guided Lung Biopsy.

Journal: Therapeutics and clinical risk management

Published: November 06, 2025

Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer.

Fully automated volumetric assessment of tumor burden using artificial intelligence on 68Ga-PSMA-11 PET predicts survival after 177Lu-PSMA therapy in metastatic Castration-resistant prostate cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: August 11, 2025

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.

TERT promoter mutations contribute to adverse clinical outcomes and poor prognosis in radioiodine refractory differentiated thyroid cancer.

Journal: Scientific reports

Published: March 21, 2024

Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer.

Deep learning based on 68Ga-PSMA-11 PET/CT for predicting pathological upgrading in patients with prostate cancer.

Journal: Frontiers in oncology

Published: August 06, 2023

Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).

Antitumour effects of apatinib in progressive, metastatic differentiated thyroid cancer (DTC).

Journal: Endocrine

Published: February 26, 2022

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.

Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11.

Journal: Bioengineered

Published: December 14, 2021

Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy.

Role of [99mTc]Tc-Galacto-RGD2 SPECT/CT in identifying metastatic differentiated thyroid carcinoma after thyroidectomy and radioactive iodine therapy.

Journal: Nuclear medicine and biology

Published: February 16, 2020

Showing 1-8 of 8

Last Updated: 09/26/2026